2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical...

19
Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint Distinct Long-term Effects of Precision X-Radiation on Reflex Saliva Flow Rate and 1 Tissue Integrity in a Preclinical Model of Chronic Hyposalivation 2 Syed Mohammed Musheer Aalam 1, *, Ishaq A. Viringipurampeer 1, *, Matthew C. Walb 2,$ , Erik J. 3 Tryggestad 2 , Chitra P. Emperumal 3 , Jianning Song 1 , Xuewen Xu 1 , Rajan Saini 4 , Isabelle M.A. 4 Lombaert 5 , Jann N. Sarkaria 2 , Joaquin Garcia 1 , Jeffrey R. Janus 3,6,7 , Nagarajan Kannan 1,7,8,# 5 1 Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA 6 2 Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA 7 3 Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, 8 USA 9 4 Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British 10 Columbia, Vancouver, British Columbia, Canada 11 5 Biointerfaces Institute, School of Dentistry, Department of Biologic and Materials Sciences, 12 University of Michigan, Ann Arbor, Michigan, USA 13 6 Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, 14 USA 15 7 Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA 16 8 Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, USA 17 $ Current affiliation: Department of Radiation Oncology and Winship Cancer Institute, Emory 18 University, Atlanta, GA 30322 19 *These authors contributed equally 20 # Corresponding author: Nagarajan Kannan Ph.D. 21 Head of Laboratory of Stem Cell and Cancer Biology 22 Mayo Clinic 23 200 First Street SW, 24 Rochester, MN, 55905, USA 25 Electronic mail: [email protected] 26 Short title: Preclinical Model of Radiation Induced Chronic Hyposalivation 27 Keywords: Xerostomia, Chronic Hyposalivation, X-Rad SmART Irradiator, Precision 28 Radiotherapy, Radiation Injury, Radiation Side Effects, Quality of Life, Preclinical Model, 29 Immunodeficient Mice, NSG-SGM3 Mice, Submandibular Gland, Parotid Gland, Sublingual 30 Gland, Precision Radiation, Stereotactic Radiation, Saliva, Saliva Flow Rate, Schirmer’s Test 31 was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (which this version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937 doi: bioRxiv preprint

Transcript of 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical...

Page 1: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

Distinct Long-term Effects of Precision X-Radiation on Reflex Saliva Flow Rate and 1

Tissue Integrity in a Preclinical Model of Chronic Hyposalivation 2

Syed Mohammed Musheer Aalam1,*, Ishaq A. Viringipurampeer1,*, Matthew C. Walb2,$, Erik J. 3 Tryggestad2, Chitra P. Emperumal3, Jianning Song1, Xuewen Xu1, Rajan Saini4, Isabelle M.A. 4 Lombaert5, Jann N. Sarkaria2, Joaquin Garcia1, Jeffrey R. Janus3,6,7, Nagarajan Kannan1,7,8,# 5

1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA 6 2Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA 7 3Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Rochester, Minnesota, 8 USA 9 4Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British 10 Columbia, Vancouver, British Columbia, Canada 11 5Biointerfaces Institute, School of Dentistry, Department of Biologic and Materials Sciences, 12 University of Michigan, Ann Arbor, Michigan, USA 13 6Department of Otolaryngology-Head and Neck Surgery, Mayo Clinic, Jacksonville, Florida, 14 USA 15 7Center for Regenerative Medicine, Mayo Clinic, Rochester, Minnesota, USA 16 8Mayo Clinic Cancer Center, Mayo Clinic, Rochester, Minnesota, USA 17 $Current affiliation: Department of Radiation Oncology and Winship Cancer Institute, Emory 18 University, Atlanta, GA 30322 19 *These authors contributed equally 20

# Corresponding author: Nagarajan Kannan Ph.D. 21 Head of Laboratory of Stem Cell and Cancer Biology 22 Mayo Clinic 23 200 First Street SW, 24 Rochester, MN, 55905, USA 25 Electronic mail: [email protected] 26

Short title: Preclinical Model of Radiation Induced Chronic Hyposalivation 27

Keywords: Xerostomia, Chronic Hyposalivation, X-Rad SmART Irradiator, Precision 28 Radiotherapy, Radiation Injury, Radiation Side Effects, Quality of Life, Preclinical Model, 29 Immunodeficient Mice, NSG-SGM3 Mice, Submandibular Gland, Parotid Gland, Sublingual 30 Gland, Precision Radiation, Stereotactic Radiation, Saliva, Saliva Flow Rate, Schirmer’s Test 31

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 2: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

Abstract 32

Chronic salivary hypofunction and xerostomia are common side effects of radiation therapy 33

which is an essential component in the curative management in patients with head & neck 34

cancers. Over the years, improvements in delivery techniques such as image-guided intensity 35

modulated radiation therapy have led to improvement in cancer management but chronic 36

hyposalivation continues to be a challenge that causes long-term health implications resulting in 37

compromised quality of life. Recent advances in salivary stem cell research promise new 38

frontier in the treatment of radiation-induced hyposalivation by initiating regeneration of 39

radiation-damaged salivary parenchymal cells. Lack of a standard preclinical immunodeficient 40

model to assess radiation-induced changes objectively and quantitatively in salivary flow rates 41

will impede rapid progress towards the development of cellular therapies for chronic salivary 42

dysfunction and attendant xerostomia. Herein, we report the first fully characterized novel cone-43

beam computed tomography (CBCT)-guided precision ionizing radiation (IR) induced chronic 44

hyposalivation model in radiosensitive, immunodeficient transgenic NSG-SGM3 mice 45

expressing three human cytokines including c-KIT ligand/stem cell factor. Additionally, we also 46

report a novel and instantaneous method to objectively assess the kinetics of pilocarpine-47

stimulated salivary flowrate. Comprehensive structural and functional characterization of 48

salivary glands revealed previously unknown and highly complex gender, age, IR dose and 49

salivary gland subtype-specific effects of salivary-ablative precision IR. 50

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 3: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

Introduction 51

Head and neck cancer accounts for ~4% of all cancers in the United States (1). The current 52

standard of care for management can involve surgery, radiation therapy, chemotherapy, 53

targeted therapy or a combination of these treatment modalities depending on various factors 54

including the stages of cancer, the surgical accessibility of the tumor, and morbidity associated 55

with each modality (2). In nearly 70% of the patients undergoing radiation therapy due to 56

location of many of these oral cancers, non-diseased adjacent tissues such as salivary 57

parenchyma is irreparably damaged due to its high sensitivity to radiation. This often results in 58

radiation-induced ‘objective’ hyposalivation or a ‘subjective’ clinical condition referred to as 59

xerostomia or dry mouth (2, 3). Complications of long-term radiation induced hyposalivation 60

include impaired taste, difficulties in speech, mastication and denture retention, increased risk of 61

dental caries and an overall compromised quality-of-life (QOL) (4). Management of 62

hyposalivation often involves the use of cholinergic drugs such as pilocarpine (5) or cevimeline 63

(6). The effectiveness of these systemic sialagogues often depends on the presence of 64

functionally-intact glandular tissue units (5). Recently, putative stem cells, that can restore the 65

salivary gland functions upon orthotopic transplantation in radioablated salivary glands of 66

recipient mice, have been reported in the submandibular glands of mice (7-9) and humans (10). 67

To compare the quality and quantity of salivary regenerative units in transplant experiments, a 68

standardized in vivo assay must be developed. However, there are several limitations with 69

currently available models of hyposalivation. 1) Their derivation involves IR and there is no 70

consensus on sources of IR, radiation fields, doses or treatment protocols. 2) A reliable method 71

to measure kinetics of stimulated reflex saliva is lacking. 3) A comprehensive characterization of 72

cellular components of radioablated salivary glands in an immunodeficient mouse model of 73

chronic hyposalivation is lacking. 4) Human salivary stem cells are suggested to express c-KIT 74

receptor, which interacts poorly with murine c-KIT ligand and therefore mouse models lacking 75

the expression of human cKIT ligand may not fully support the engraftment of human salivary 76

stem cells (10). These lacunae need to be addressed before such preclinical models could be 77

routinely used for human salivary stem cell evaluation. Therefore, in the present study, based 78

on comprehensively characterization of precision irradiated male and female (young and old) 79

immunodeficient transgenic NSG-SGM3 mice expressing human c-KIT ligand, we have 80

identified suitable models for chronic hyposalivation studies for preclinical assessment of 81

experimental therapies. Further, we demonstrate Schirmer’s test as an accurate, reliable 82

method to assess quantitative changes in saliva flow rate in real time in our hyposalivation 83

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 4: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

model. Moreover, characterization of salivary glands at necropsy further revealed highly 84

complex gender, age, IR dose and salivary gland subtype-specific effects of salivary-ablative 85

precision IR in NSG-SGM3 mice. In summary, we have developed the first humanized mouse 86

model that mimics a challenging, chronic lifestyle problem in cancer survivors, which provides a 87

robust platform to enable studies to measure regenerative outcome following patient-derived 88

salivary cell transplants. 89

Results and Discussion 90

To generate a preclinical model of chronic hyposalivation here in, we utilized 3D image guided 91

stereotactic X-RAD SmART+small animal irradiator system (Precision X-ray Inc., North 92

Bradford, CT) to radioablate the major salivary glands of immunodeficient NSG-SGM3 93

(NOD.Cg- Prkdcscid Il2rgtm1Wjl Tg (CMV-IL3, CSF2, KITLG) mice (11). Details of the functionality 94

of this irradiator are described elsewhere (12-14). Dosimetric calculations were performed with 95

an in-house 1D “point dose calculator” (PDC) tool developed by our medical physics group to 96

enable efficient dose calculations (single prescription reference point on the central beam axis) 97

(15). This simple 1D PDC was verified using the vendor supplied 3D Monte Carlo treatment 98

planning system, SmART-ATP version 1.1 (SmART Scientific Solutions B.V., Maastricht, 99

Netherlands), which is based on the open-source Monte Carlo code (EGSnrc/BEAMnrc)(16, 17) 100

(Fig1A&B). The chosen beam arrangement was parallel opposed beams using a 10 mm circular 101

collimator, with tipped laterals (89º and 271º) aligned to match beam divergence along the brain 102

edge in order to maximize brain sparing and achieve specific targeting of major salivary glands 103

along the midline of the mouse in the neck region (Fig1C (i-iii)). The individual young (~21 104

weeks) male or female or old (~53 weeks) female mouse was restrained on a bite block using 105

an anesthesia nose cone and imaged with cone beam computed tomography (CBCT). 106

Subsequently, CBCT image-guidance defined target and single radiation dose ranging from 0–107

7.5 Gy for young and old mice was delivered at target site i.e., major salivary glands. Both sham 108

and precision IR treated mice were followed for 6 months. The young mice precision irradiated 109

with 5 Gy showed transient alopecia whereas, higher dose of 7.5 Gy showed permanent 110

alopecia in the mandibular region (Fig1D). However, we did not observe any significant change 111

in body weight of young or old mice (Fig1E) throughout the study period or precision IR related 112

mortality (Fig1F), which suggests that both male and female Prkdcscid mutant highly 113

radiosensitive NSG-SGM3 mice are able to tolerate Sub-lethal dose is 3.5 Gy (18) of IR when 114

delivered in a stereotactic manner on the major glands. 115

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 5: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

Salivary stimulation and secretion is a nerve-mediated reflex action modulated by the central 116

nervous system in response to a stimulus, and this activity is an important indicator of functional 117

health of salivary glands (19). In hyposalivation animal models, cholinergic drugs such as 118

pilocarpine or carbachol are often used to stimulate saliva secretion (10, 20, 21). Although, 119

there are several methods that have been reported to collect stimulated reflex saliva and 120

evaluate changes in salivary flow rate in vivo or ex vivo (Supplementary table1), the field lacks 121

an operator independent and objective method for instantaneous kinetic measurement of 122

stimulated saliva flowrate in vivo. Therefore, we adopted Schirmer’s test strip method to assess 123

quantitative changes in salivary flow rate in NSG-SGM3 mice. Schirmer’s tests are used in 124

clinical practice to measure eye dryness (22). We tested this method against the most 125

commonly used gravimetric method. We injected 2 mg/kg of pilocarpine sub-cutaneously 126

(SubQ) into the dorsal flanks of mice and started continuously collecting saliva 5 minutes post-127

injection from the floor of mouth using pre-weighed filter paper or Schirmer’s test strips for 30 128

minutes. The filter paper or Schirmer’s test strips were changed every five minutes and saliva 129

migration under the capillary action (mm) was recorded. Subsequently, weight of blotted strips 130

was determined gravimetrically (Fig2A). Schirmer’s test demonstrated gender-specific and age-131

specific differences in stimulated reflex saliva flow rate captured over 30 minutes. The saliva 132

secretion peaks at 10 minutes after stimulation in all mice irrespective of gender, age or 133

radiation treatment and declines thereafter (Fig2B). Sexual dimorphism was reported in 134

submandibular gland (SMG) in mouse models with respect to the unique presence of granular 135

convoluted tubular structures in male mice (23). We found such structures in SMG of male 136

NSG-SGM3 only (Supplementary Fig 1). Additionally, Schirmer’s test distinguished young 137

female mice having significantly lower initial stimulated saliva flowrates compared to young male 138

and old female mice at -1 weeks and +3 weeks of sham-irradiation (Fig2B). Notably, the old 139

female mice exhibited relatively more rapid secretory loss after 10 min (Fig2B). This trend was 140

consistent during the 6-7 month measurement period in sham irradiated mice. Furthermore, 141

various measurements of saliva fraction over the period of 24 weeks in young male and female 142

mice demonstrated that our Schirmer’s test strip method was highly correlated with gravimetric 143

method in both male (R2=0.9031, p<0.0001) and female (R2=0.7289, p<0.0001) NSG-SGM3 144

mice (Fig2D). Taken together, our results suggest that Schirmer’s test strips offer a, rapid and 145

reliable quantitative method to assess real-time change in saliva flow rate in mice. This method 146

can be easily adapted to study saliva flow rate in other mouse strains and species. Moreover, 147

Schirmer’s test strips circumvent the variability associated with salivary collection and 148

measurement methods. In fact, in our study the saliva measurement with Schirmer’s test strips 149

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 6: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

was found to be consistent between three independent operators (data not shown). Salivary 150

gland hypofunction resulting in chronic hyposalivation is often one of the consequences 151

associated with radiotherapy of head and neck malignancies. Patients with such complications 152

experience QOL or oral health issues (4). Modeling chronic radiation-induced hyposalivation in 153

animals has been challenging, as there is no consensus on radiation dose, gender, age and 154

duration of the study period. Therefore, we systematically characterized stereotactic radiation 155

dose-dependent chronic reflex hyposalivation in preclinical NSG-SGM3 model. We determined 156

the kinetics of pilocarpine stimulated reflex saliva flow rates over the course of 30 minutes using 157

Schirmer’s test strips in young male, female and old female mice irradiated with 0, 2.5, 5 and 158

7.5 Gy doses. At 24 weeks post-irradiation, we observed significant delay in the onset of 159

stimulated reflex saliva secretion and reduction in salivary flowrates in mice irradiated with 160

radiation doses of 5 and 7.5 Gy compared to 0 Gy controls (Fig3A). However, mice irradiated 161

with 2.5 Gy dose showed a marginal decline in stimulated reflex saliva flowrate compared to 0 162

Gy controls in young male and female mice (Fig3A). Moreover, at early time points (5 and 10 163

min) following pilocarpine stimulation, salivary flow rate is significantly different between young 164

male and female mice at the high doses (5 and/or 7.5 Gy) (pvalue < 0.0055 and 0.0023) 165

(Fig3B). Further, to assess chronic hyposalivation in our pre-clinical NSG-SGM3 model, we 166

continued the measurement of stimulated reflex saliva flow rate until a period of 6 months post-167

irradiation. We observed marked reduction in stimulated reflex saliva fraction immediately 168

following irradiation in young male, young female and old female mice. After 2 months post-169

irradiation with 5 and 7.5 Gy doses, the stimulated reflex saliva flow rate stabilized at 50% and 170

was sustained until the endpoint of 6 months relative to 0 Gy controls (Fig3C&D). Interestingly, 171

mice irradiated with 2.5 Gy dose showed initial decline in stimulated reflex saliva flow rate, but 172

this was followed by restoration as early as 3 weeks after irradiation although not to the extent 173

similar to that of 0 Gy controls (Fig3C&D). This restoration of salivary flowrate could be partially 174

attributed to ongoing salivary stem cell activity that may contribute to functional recovery of the 175

gland. Interestingly, starting at 2 months (+6 week and +24 week post-IR), the fraction of saliva 176

in young females was significantly lower compared to young male mice (Fig3D). 177

Radiation-induced salivary gland injury is also associated with glandular shrinkage, loss of 178

acinar cell area, inflammation, fibrosis, microvascular injury and atrophy (24). Therefore, at the 179

endpoint of 24 weeks, we sacrificed sham and irradiated mice and performed neck dissection to 180

harvest salivary gland tissue. Overall the sham-irradiated whole salivary glands were 181

significantly larger in old female mice than young female mice relative to their body weight 182

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 7: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

(Fig4A). At necropsy, we observed glandular shrinkage irrespective of gender and age in 183

cohorts of mice irradiated with 5 and 7.5 Gy doses albeit glandular shrinkage was not evident 184

with 2.5 Gy dose in comparison to 0 Gy controls (Fig4B-C). Consistently, we observed 185

significant dose dependent reduction in salivary gland weight in young and old female mice 186

(Fig4C). Interestingly, we did not observe any correlation between radiation doses and salivary 187

gland weight in young male mice due to variability across the radiation doses (Fig4C). Further, 188

we prepared tissue sections from harvested parotid, submandibular and sublingual glands of 189

young female mice irradiated with 0 and 7.5 Gy doses and performed histological and 190

immunohistochemical analysis. Hematoxlin and Eosin (H&E) staining revealed gross changes in 191

tissue morphology and loss of acinar and ductal cells in all major salivary glands of irradiated 192

mice when compared to controls (Fig4D-i). Similarly, Sirius red (Fig4D-ii) and trichrome (Fig4D-193

iii) staining showed thickening of collagen fibers and fibrosis in tissue sections obtained from 194

irradiated mice when compared to controls. Moreover, to assess the extent of radiation induced 195

damage to salivary epithelium, we stained whole salivary tissue sections for epithelial cell 196

marker EpCAM by immunostaining (25). We observed reduced expression of EpCAM in salivary 197

epithelium of irradiated mice compared to controls, which could be attributed to the loss of 198

functional ducts and acini (Fig4D-iv). To validate this observation we performed immunostaining 199

for Aquaporin 5 (Aqp5), a membrane protein that facilitates water movement across the 200

basal/lateral/ apical membrane in acinar cells (26). Consistently, our results revealed reduction 201

in expression of Aqp5 in acinar cells of irradiated mice compared to controls (Fig4D-v). 202

Interestingly, we observed higher expression of β-catenin in ductal cells of irradiated mice 203

relative to controls (Fig4D-v), suggesting ongoing tissue remodeling activity (25, 27, 28). In 204

addition, we performed immunostaining of NKCC1, a cotransporter highly expressed in baso-205

lateral membrane of acinar cells. We observed reduced expression of NKCC1 in submandibular 206

glands of irradiated mice when compared to controls (Fig4D-vi). However, we did not observe 207

any changes in NKCC1 expression in parotid and sublingual glands in irradiated and control 208

mice. 209

The advantages of developing precision-IR based female NSG-GSM3 as a chronic 210

hyposalivation model for preclinical testing are manifold. Animal: These mice express human 211

interleukin-3 (hIL3), human granulocyte monocyte colony stimulating factor (hGM-CSF) and 212

human c-Kit ligand also known as human stem cell factor (hSCF), which makes them ideal to 213

study the regenerative properties of c-KIT-expressing putative human salivary stem cells (10). 214

Male NSG-SGM3 mice, like other rodents (23, 29), have granular convoluted tubular structures 215

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 8: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

which are absent in human. Both young and old female mice are suitable models, but young 216

female mice will perhaps offer quicker test results. The earliest post-IR timepoint which indicates 217

stabilization of flow rate fluctuations in these female mice are around 2 months post-irradiation. 218

We recommend this as the earliest timepoint to assess chronic hyposalivation levels. Precision 219

IR: The presence of Prkdcscid mutation makes these mice radiosensitive due to the lack of 220

functional DNA repair machinery (11). Head & neck radiation to overcome this issue may lead to 221

cognitive and other brain defects (30). Therefore, precision IR enables hyposalivation studies 222

using 5-7.5 Gy doses over chronic timeline irrespective of gender or age. These mice are 223

available at Jackson Laboratories and breed well under standard conditions. Schirmer’s test: 224

Each strip costs around 0.3US Dollar. Single kinetic measurement of a flow rate over 30 225

minutes in a single animal requires 6 strips. The reading can be noted real-time or a pencil mark 226

is sufficient to analyze the strips later with no concerns of evaporation. 227

On the basis of our characterization of immunodeficient NSG-SGM3 mice following brain-228

sparing precision IR of salivary glands, we propose a novel chronic hyposalivation model for 229

regenerative medicine and human cell therapy studies. 230

Methods: 231

Animals: Female and male NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CMV-232

IL3,CSF2,KITLG)1Eav/MloySzJ mice (8-12 weeks old) were purchased from Jackson 233

Laboratories and maintained at Mayo Clinic animal facility. Experimental mice were housed in 234

barrier facility and fed ad libitum with food pellets and acidified water. All procedures were 235

approved by Mayo Clinic’s Institutional Animal Care and Use Committee (IACUC). 236

Salivary targeted precision IR set-up: Each mouse was anesthetized via isoflurane for the 237

duration of the procedure via a nose cone delivery system on a bite block, and placed in a Feet 238

First Prone (FFP) position in the irradiation chamber. A commercially- available stereotactic 239

stage (Model 900M, Kopf Instruments, Tujunga, CA) was modified to facilitate mounting to the 240

X-RAD SmART irradiator (31) (Fig1A). X-ray irradiation (0, 2.5, 5 or 7.5 Gy; at ~5Gy/min dose 241

rate) using X-RAD SmART irradiator was delivered to head and neck in a brain-sparing manner. 242

The stereotactic X-RAD SmART irradiator set-up doesn't require additional blocking. In brief, 243

each mouse was volumetrically imaged with CBCT (60 kVp, 0.3 mA, 2.0 mm Al filter, 256 244

projections 0.2 mm3 voxel size). Subsequently, the filter was switched to high energy copper 245

(irradiation) filter and beam is focused on the target using 10 mm circular collimator for brain-246

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 9: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

sparing salivary-ablative radiation treatment. Each mouse was under isoflurane anesthesia for 247

about 10 min to complete the irradiation procedure. 248

Pilocarpine-stimulated reflex saliva flow measurements: Animals were anesthetized using 249

2% isoflurane and injected sub-cutaneously with 2 mg/kg pilocarpine, a cholinergic drug. After 5 250

minutes, animals were restrained and the secreted saliva was collected continuously from the 251

floor of the mouth using pre-weighed Schirmer’s test strips (Tearflo, HUB Pharmaceuticals LLC, 252

Rancho Cucamonga, CA, USA) for a period of 30 minutes. The strips were changed every five 253

minutes and the distance of saliva migration under the capillary action (mm) was recorded. 254

Subsequently, the weight of blotted strips was determined gravimetrically. Saliva was measured 255

every three weeks interval in all groups of mice for a period of 24 weeks. The rate of saliva 256

secretion by Schirmer’s test and gravimetry was determined in irradiated and sham treated 257

animals. 258

Histology and immunostaining: Mouse major salivary glands were fixed in 10% formalin 259

buffer fixative (fisher scientific; SF-1004) for 1 h prior to processing. Paraffin-embedded salivary 260

glands tissues sections (5μm thick) were stained with Hematoxylin and Eosin (H&E; 261

morphological changes), trichrome, and red stain (collagen). Stained slides were photographed 262

using color brightfield imaging with Cytation5 (BioTek Instruments Agilent Technologies, USA). 263

For immunostaining, 5 μm sections salivary tissues were deparaffinized with xylene, rehydrated 264

in graded ethanol and rinsed with distilled water. Slides were rehydrated and antigens retrieved 265

by boiling slides for 20 minutes in antigen unmasking solution (Vector Laboratories Inc, 266

Burlingame, CA, USA). Sectioned tissues were incubated overnight at 4°C with desired primary 267

antibody anti-EpCAM antibody conjugated with Alexa Fluor 488, (Abcam, ab237384 1:200 268

dilution), anti-NKCC1(Abcam, ab59791; 1;250), anti- Aquaporin-5 (Sigma-Aldrich, AB15858, 269

1:200), or anti-β catenin conjugated with Alexa Fluor 647 (Abcam, ab194119; 1;250) diluted in 270

blocking buffer (2% normal goat serum, 0.1% Triton X-100 in PBS). After three washes in PBS-271

Tween 20 (PBST), sections were incubated for 1 h with secondary antibody (Alexa Fluor® 488 272

goat anti-rabbit IgG (ThermoFisher Scientific, A-11008, 1:200), or Alexa Fluor® 594 goat anti-273

rabbit IgG (ThermoFisher Scientific, A-11012, 1:200) diluted in PBS, containing 2% normal goat 274

serum. Nuclei were counterstained with DAPI Fluoromount-G® (Southern Biotech, Birmingham, 275

AL, USA). 276

Statistical Analysis: Analyses were performed using GraphPad Prism 8.0. For parameteric 277

comparisons between treated and untreated groups, an unpaired two-tailed Student’s t-test was 278

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 10: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

utilized. P-values of < 0.05 were considered significant. Multiple group comparison was 279

performed by one-way or two-way ANOVA. Differences were considered significant at P < 0.05. 280

Results are reported as mean ± SEM unless otherwise stated. 281

Contributions: SA and IV conducted experiments and analyzed the results, performed 282

statistical analysis, and wrote the manuscript. ET, MW and JS assisted with SmART technology 283

and stereotactic radiotherapy design and dosimetry. JS, XX and CE assisted with data 284

collection. RS and JG assisted with interpretation of histology and immunohistochemistry data. 285

IV performed statistical analysis. IL provided insight on current saliva collection methods. JJ and 286

NK conceptualized and designed the study, interpreted the data, and wrote the manuscript. NK 287

supervised the study. All authors contributed to the drafting of the manuscript. 288

Acknowledgments: This study was supported by Mayo Clinic and in part by grants to JJ and 289

NK from Mayo Clinic Center for Regenerative Medicine. We thank Dr. James E. Melvin 290

(NIH/NIDCR) for helpful discussions on salivary measurement methods, and Drs. Geng Xian 291

Shi and Gang Liu for their technical assistance. 292

References: 293

1. Siegel RL, Miller KD, and Jemal A. Cancer Statistics, 2017. CA: a cancer journal for 294

clinicians. 2017;67(1):7-30. 295

2. Vissink A, Burlage FR, Spijkervet FK, Jansma J, and Coppes RP. Prevention and 296

treatment of the consequences of head and neck radiotherapy. Critical reviews in oral 297

biology and medicine : an official publication of the American Association of Oral 298

Biologists. 2003;14(3):213-25. 299

3. Sun HB, Gao XJ, Deng J, Li NY, and Lu HJ. Progress of oral sequelae during head-neck 300

radiotherapy. The Chinese journal of dental research : the official journal of the Scientific 301

Section of the Chinese Stomatological Association. 2010;13(1):51-5. 302

4. Villa A, Connell CL, and Abati S. Diagnosis and management of xerostomia and 303

hyposalivation. Ther Clin Risk Manag. 2015;11:45-51. 304

5. Takakura AC, Moreira TS, Laitano SC, De Luca Junior LA, Renzi A, and Menani JV. 305

Central muscarinic receptors signal pilocarpine-induced salivation. J Dent Res. 306

2003;82(12):993-7. 307

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 11: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

6. Chambers MS, Jones CU, Biel MA, Weber RS, Hodge KM, Chen Y, et al. Open-label, 308

long-term safety study of cevimeline in the treatment of postirradiation xerostomia. Int J 309

Radiat Oncol Biol Phys. 2007;69(5):1369-76. 310

7. Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, Kok T, et al. Rescue 311

of salivary gland function after stem cell transplantation in irradiated glands. PLoS One. 312

2008;3(4):e2063. 313

8. Mishima K, Inoue H, Nishiyama T, Mabuchi Y, Amano Y, Ide F, et al. Transplantation of 314

side population cells restores the function of damaged exocrine glands through clusterin. 315

Stem Cells. 2012;30(9):1925-37. 316

9. Nanduri LS, Lombaert IM, van der Zwaag M, Faber H, Brunsting JF, van Os RP, et al. 317

Salisphere derived c-Kit+ cell transplantation restores tissue homeostasis in irradiated 318

salivary gland. Radiother Oncol. 2013;108(3):458-63. 319

10. Pringle S, Maimets M, van der Zwaag M, Stokman MA, van Gosliga D, Zwart E, et al. 320

Human Salivary Gland Stem Cells Functionally Restore Radiation Damaged Salivary 321

Glands. Stem Cells. 2016;34(3):640-52. 322

11. Wunderlich M, Chou FS, Link KA, Mizukawa B, Perry RL, Carroll M, et al. AML xenograft 323

efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing 324

human SCF, GM-CSF and IL-3. Leukemia. 2010;24(10):1785-8. 325

12. Verhaegen F, Granton P, and Tryggestad E. Small animal radiotherapy research 326

platforms. Phys Med Biol. 2011;56(12):R55-83. 327

13. Stewart JM, Ansell S, Lindsay PE, and Jaffray DA. Online virtual isocenter based 328

radiation field targeting for high performance small animal microirradiation. Phys Med 329

Biol. 2015;60(23):9031-46. 330

14. Clarkson R, Lindsay PE, Ansell S, Wilson G, Jelveh S, Hill RP, et al. Characterization of 331

image quality and image-guidance performance of a preclinical microirradiator. Med 332

Phys. 2011;38(2):845-56. 333

15. Smith EJ, Tryggestad EJ, Carlson BL, Walb MC, and Sarkaria JN. Imaging and 334

Dosimetry Study of Inter-fraction Setup Error in a Murine Xenograft Flank Tumor 335

Radiation Model. Radiat Res. 2020;193(2):161-70. 336

16. van Hoof SJ, Granton PV, and Verhaegen F. Development and validation of a treatment 337

planning system for small animal radiotherapy: SmART-Plan. Radiother Oncol. 338

2013;109(3):361-6. 339

17. Rogers DW, Faddegon BA, Ding GX, Ma CM, We J, and Mackie TR. BEAM: a Monte 340

Carlo code to simulate radiotherapy treatment units. Med Phys. 1995;22(5):503-24. 341

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 12: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

18. Nicolini FE, Cashman JD, Hogge DE, Humphries RK, and Eaves CJ. NOD/SCID mice 342

engineered to express human IL-3, GM-CSF and Steel factor constitutively mobilize 343

engrafted human progenitors and compromise human stem cell regeneration. Leukemia. 344

2004;18(2):341-7. 345

19. Proctor GB. The physiology of salivary secretion. Periodontol 2000. 2016;70(1):11-25. 346

20. Nanduri LS, Maimets M, Pringle SA, van der Zwaag M, van Os RP, and Coppes RP. 347

Regeneration of irradiated salivary glands with stem cell marker expressing cells. 348

Radiother Oncol. 2011;99(3):367-72. 349

21. Gilman KE, Camden JM, Klein RR, Zhang Q, Weisman GA, and Limesand KH. P2X7 350

receptor deletion suppresses gamma-radiation-induced hyposalivation. Am J Physiol 351

Regul Integr Comp Physiol. 2019;316(5):R687-R96. 352

22. Senchyna M, and Wax MB. Quantitative assessment of tear production: A review of 353

methods and utility in dry eye drug discovery. J Ocul Biol Dis Infor. 2008;1(1):1-6. 354

23. Maruyama CL, Monroe MM, Hunt JP, Buchmann L, and Baker OJ. Comparing human 355

and mouse salivary glands: A practice guide for salivary researchers. Oral Dis. 356

2019;25(2):403-15. 357

24. Grundmann O, Mitchell GC, and Limesand KH. Sensitivity of salivary glands to radiation: 358

from animal models to therapies. J Dent Res. 2009;88(10):894-903. 359

25. Maimets M, Rocchi C, Bron R, Pringle S, Kuipers J, Giepmans BN, et al. Long-Term In 360

Vitro Expansion of Salivary Gland Stem Cells Driven by Wnt Signals. Stem Cell Reports. 361

2016;6(1):150-62. 362

26. Hosoi K, Yao C, Hasegawa T, Yoshimura H, and Akamatsu T. Dynamics of Salivary 363

Gland AQP5 under Normal and Pathologic Conditions. Int J Mol Sci. 2020;21(4). 364

27. Hai B, Yang Z, Millar SE, Choi YS, Taketo MM, Nagy A, et al. Wnt/beta-catenin signaling 365

regulates postnatal development and regeneration of the salivary gland. Stem Cells Dev. 366

2010;19(11):1793-801. 367

28. Hai B, Yang Z, Shangguan L, Zhao Y, Boyer A, and Liu F. Concurrent transient 368

activation of Wnt/beta-catenin pathway prevents radiation damage to salivary glands. Int 369

J Radiat Oncol Biol Phys. 2012;83(1):e109-16. 370

29. Gresik EW. The granular convoluted tubule (GCT) cell of rodent submandibular glands. 371

Microsc Res Tech. 1994;27(1):1-24. 372

30. Zer A, Pond GR, Razak ARA, Tirona K, Gan HK, Chen EX, et al. Association of 373

Neurocognitive Deficits With Radiotherapy or Chemoradiotherapy for Patients With Head 374

and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2018;144(1):71-9. 375

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 13: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

31. Walb MC, Carlson BL, Sarkaria JN, and Tryggestad EJ. Quantifying the setup 376

uncertainty of a stereotactic murine micro-image guided radiation therapy system. Br J 377

Radiol. 2019;92(1095):20180487. 378

379

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 14: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

Figure Legends 380

Figure 1. Effects of CBCT-guided stereotactic salivary-ablative precision IR on aging 381

highly immunodeficient and partially humanized NSG-SGM3 mice. A) A photograph 382

showing a dummy mouse restrained on stereotactic stage of the X-RAD SmART irradiator. B) 383

Dosimetry and angle of delivery calculated using vendor supplied Monte Carlo treatment 384

planning system. C) Representative images showing CBCT-guided target placement at the 385

midline of the mouse neck region; (i) axial, (ii) sagittal, and (iii) temporal views. D) 386

Representative head and neck image highlighting chronic alopecia in neck region associated 387

with 0, 2.5, 5 and 7.5 Gy IR (female; n=5 for each group). E) Body weight (in grams) and age (in 388

months) of NSG-SGM3 mice used in this study; male (n=19), female (n=20) and old female 389

(n=20). F) Long-term survival plot in young mice showing lack of precision radiation associated 390

mortality (male n=19; female n=20). 391

Figure 2. Objective and instantaneous assessment of pilocarpine-stimulated reflex saliva 392

flow in preclinical NSG-SGM3 model. A) Illustration of workflow to measure pilocarpine-393

stimulated reflex saliva flow by Schirmer’s test strips and gravimetry. B) Kinetics of pilocarpine-394

stimulated reflex saliva flowrate (µg/min) in NSG-GSM3 mice (male (n=5), female (n=5) and old 395

female (n=4). C) Barplot showing gender and age differences in saliva flowrate at 10 and 25 396

mins post-stimulation male (n=5), female (n=5) and old female (n=4). C) X-Y plot showing 397

correlation between gravimetric vs Schirmer’s test method based detection of pilocarpine-398

stimulated reflex saliva fraction in male and female mice (male (n=19) ; female (n=20); *denotes 399

p<0.01. 400

Figure 3. Effects of precision IR doses on chronic hyposalivation in preclinical NSG-401

SGM3 model. A) Kinetics of pilocarpine-stimulated reflex saliva flow rate (µg/min) in mice 402

treated with different precision IR doses (male (n=5 all groups except for 7.5Gy IR dose n=4); 403

female n=5 or n=4 old female for each experimental group). B) Gender -and age-specific 404

significant differences in pilocarpine-stimulated reflex saliva fraction in mice treated with 405

different precision IR doses. Data is relative to respective sham treated controls (male (n=5 all 406

groups except for 7.5Gy IR dose n=4); female n=5 or old female n=4 for each experimental 407

group). C) High-dose precision irradiated mice displaying delayed onset of stimulated reflex 408

saliva flowrate in time (0, 2, 4, 6 months) (male (n=5 all groups except for 7.5Gy IR dose n=4; 409

female n=5 or old female n=4 for each experimental group). D) Barplot showing significant 410

changes in saliva fraction at +3, +6, and +24 weeks in irradiated young male, female and old 411

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 15: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint

female mice relative 0 Gy controls (male (n=5 all groups except for 7.5Gy IR dose n=4; female 412

n=5 or old female n=4 for each experimental group.*p<0.01; **p<0.001 and ***p<0.0001 413

Figure 4. Assessment at necropsy reveals 6 month post-precision IR associated changes 414

on salivary tissue, stroma, epithelial cell polarity, and integrity in preclinical NSG-SGM3 415

model. A) Barplot showing baseline differences in wet weight of total salivary gland tissue 416

(mg/g body weight) obtained from mice at the time of necropsy (male n=19; female n=20 or old 417

female n=20. B) Representative photo micrograph illustrating precision 7.5 IR induced total 418

salivary tissue volume reduction at necropsy compared to sham treated control young female 419

mouse. C) X-Y plot showing precision IR dose dependent changes in the body weight adjusted 420

wet weight of total salivary tissue in mg (male n=5 except n=4 for 7.5Gy IR dose; female n=5 or 421

old female n=4 for each experimental group. D) Photomicrograph of stained parotid, 422

submandibular and sublingual glands of young female NSG-GM3 mice at 6 month post-IR (0 423

and 7.5 Gy). Five micron sections were stained with (i) H&E, (ii) Sirius red, (iii) Trichrome, (iv) 424

EpCAM (v) Aquaporin 5/beta-catenin and (vi) NKCC1 (female n=3). ns denotes not significant; 425

**p<0.001. 426

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 16: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

A B

0 Gy 2.5 5 7.5

(i) (ii) (iii)

N

VNT

S

I

NT

S

I

Group

Precision IRdose (Gy)

Total X-ray dose

(Gy)

89° 271°

1 0 0 02 1.25 1.25 2.53 2.5 2.5 54 3.75 3.75 7.5

C

D

E

% c

hang

e in

bod

y w

eigh

t

0 1 2 3 4 5 60

25

50

75

100

125

150

% s

urvi

val

F

Month post-precision IR0 1 2 3 4 5 6

0

50

100

0 2.5 5 7.5

0 1 2 3 4 5 60

25

50

75

100

125

150

0 1 2 3 4 5 60

25

50

75

100

125

150 Young Young Old

0 2.5 57.5

0 2.5 57.5

0 2.5 57.5

Figure 1

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 17: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

0 5 10 15 20 25 300 5 10 15 20 25 300 5 10 15 20 25 300

10

20

30

*

0

10

20

30

40

*

*

***

*

*

10 10 1025 25 25Minutes post-stimulation

-3 weeks -1 weeks +3 weeks

Flow

rate

(µg/

min

)

-3 weeks -1 weeks +3 weeks

B

5 minute intervals

SubQ

Weighing scale

A

0 30

Gravimetric method Schirmer’s test

Isofluraneinduction

Pilocarpinestimulation

Saliva flowrate measurement

Saliva fraction (Schirmer’s test)

Saliv

a fra

ctio

n (G

ravi

met

ric )

C

R²= 0.7289p<0.0001

0.2 0.4 0.6 0.8 1.00.2

0.4

0.6

0.8

1.0

0.2 0.4 0.6 0.8 1.00.2

0.4

0.6

0.8

1.0R²=0.9031p<0.0001

Saliv

a fra

ctio

n (G

ravi

met

ric )

Old

Figure 2

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 18: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

Minutes post-stimulation

Frac

tion

of s

aliva

+3 week post-IR

Flow

rate

(µg/

min

)

Young

Young

Old

+6 week post-IR +24 week post-IR

A B

D

C

7.5 Gy5 Gy2.5 Gy0 Gy

7.5 Gy5 Gy2.5 Gy0 Gy

+24 weeks post-IR

0 10 20 300

10

20

30

0 10 20 300

10

20

30

0 10 20 300

10

20

30

0 2 4 60.4

0.6

0.8

1.0

***

***

0 2 4 60.4

0.6

0.8

1.0

***

***

Frac

tion

of s

aliv

a

Young

Young

Old

Months post-irradiation0 2 4 6

0.4

0.6

0.8

1.0

***

***

0

40

** **

10 min post-stimulation

5 min post-stimulation

Flow

rate

(µg/

min

)

Old

Old

Old

Old

10

20

30

0

10

20

30

40

** **

Old

Old

Old

Old

+24 weeks post-IR

0.4

0.6

0.8

1.0

1.2****

0.4

0.6

0.8

1.0

1.2

*

0.4

0.6

0.8

1.0

1.2

******

Old

Old

Old

Old

Old

Old

O Old

Old

Old

Old

O

Figure 3

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint

Page 19: 2 Tissue Integrity in a Preclinical Model of Chronic …...2020/05/26  · Aalam et al. Preclinical Model of Chronic Hyposalivation Preprint 116 Salivary stimulation and secretion

0

5

10

15

20

Old

Parotid Submandibular Sublingual

i. H

&Eii.

Siri

us R

ed

v. A

quap

orin

-5/β-Catenin

/DAP

I

A B C

D

Saliv

ary

tissu

e (m

g/g

body

)

0 0 0

7.5 7.5 7.5

0 0 0

7.5 7.5 7.5

vi. N

KCC1/

DAP

I

0 0 0

7.5 7.5 7.5

0 0 0

7.5 7.5 7.5

0 Gy

7.5 Gy

**

ns

Parotid Submandibular Sublingual

iii. T

richr

ome

0 0 0

7.5 7.5 7.5

iv. EpC

AM/D

API

0 0 0

7.5 7.5 7.5

Figure 4

R2 = 0.941p = 0.05

R2 = 0.976p = 0.012

R2 = 0.213p = 0.538

Old

Saliv

ary

tissu

e (m

g/g

body

)

0.0 2.5 5.0 7.54

6

8

10

12

14

16

was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The copyright holder for this preprint (whichthis version posted May 30, 2020. ; https://doi.org/10.1101/2020.05.26.117937doi: bioRxiv preprint